Analyst Ratings for Trius Therapeutics (TSRX)
TSRX Rating Summary
TSRX Price Target Summary
- Highest: $20.00 (Guggenheim)
- Lowest: $7.00 (WBB Securities)
- Average: $12.50
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.50 (+44.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2013 | Guggenheim | New Coverage | Buy (N/A) |
20.00 (N/A) |
6.61 | 8.63 | 30.56% | Details |
| 11/27/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
10.00 (N/A) |
4.91 | 8.63 | 75.76% | Details |
| 11/19/2012 | Aegis Capital | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.74 | 8.63 | 82.07% | Details |
| 11/6/2012 | Baird | New Coverage | Outperform (N/A) |
11.00 (N/A) |
5.41 | 8.63 | 59.52% | Details |
| 8/29/2012 | WBB Securities | New Coverage | Buy (N/A) |
7.00 (N/A) |
5.49 | 8.63 | 57.19% | Details |
| 6/15/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
13.00 (N/A) |
5.09 | 8.63 | 69.55% | Details |
| 12/5/2011 | Oppenheimer » Updated 9/12/2012 |
New Coverage | Outperform (N/A) |
12.00 (N/A) |
7.46 | 8.63 | 15.68% | Details |
| 5/26/2011 | Global Hunter Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
8.09 | 8.63 | 6.67% | Details |
| 5/25/2011 | BofA/Merrill Lynch | New Coverage | Buy (N/A) |
N/A (N/A) |
7.98 | 8.63 | 8.15% | Details |
| 3/29/2011 | Ladenburg Thalmann | New Coverage | Buy (N/A) |
N/A (N/A) |
5.30 | 8.63 | 62.83% | Details |
| 9/14/2010 | JMP Securities | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
4.30 | 8.63 | 100.7% | Details |
| 9/13/2010 | Canaccord Genuity » Updated 1/17/2012 |
New Coverage | Buy (N/A) |
12.00 (N/A) |
4.00 | 8.63 | 115.75% | Details |
| 9/13/2010 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
4.00 | 8.63 | 115.75% | Details |
| 9/13/2010 | Citi | New Coverage | Buy (N/A) |
N/A (N/A) |
4.00 | 8.63 | 115.75% | Details |
